Clinical Trials Directory

Trials / Completed

CompletedNCT00319033

Open-label Study With Bosentan in Interstitial Lung Disease

Long-term Open-label Study in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis Who Completed the Protocol AC-052-330.

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
132 (planned)
Sponsor
Actelion · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will asses the long term safety and efficacy of oral bosentan to patients suffering from Interstitial Lung Disease.

Conditions

Interventions

TypeNameDescription
DRUGbosentan

Timeline

Start date
2004-07-01
Primary completion
2006-02-01
Completion
2006-02-01
First posted
2006-04-27
Last updated
2025-02-03

Source: ClinicalTrials.gov record NCT00319033. Inclusion in this directory is not an endorsement.

Open-label Study With Bosentan in Interstitial Lung Disease (NCT00319033) · Clinical Trials Directory